ID26972A - TIOESTER ASAM S-SUBSTITUSI 11β-BENZALDOKSIN ESTRA-4,9-DIENAKARBONAT, PROSES UNTUK MEMBUAT DAN SEDIAAN FARMASI YANG TERDIRI DARI SENYAWA INI - Google Patents
TIOESTER ASAM S-SUBSTITUSI 11β-BENZALDOKSIN ESTRA-4,9-DIENAKARBONAT, PROSES UNTUK MEMBUAT DAN SEDIAAN FARMASI YANG TERDIRI DARI SENYAWA INIInfo
- Publication number
- ID26972A ID26972A IDW20001706A ID20001706A ID26972A ID 26972 A ID26972 A ID 26972A ID W20001706 A IDW20001706 A ID W20001706A ID 20001706 A ID20001706 A ID 20001706A ID 26972 A ID26972 A ID 26972A
- Authority
- ID
- Indonesia
- Prior art keywords
- estra
- tioester
- dienacarbonate
- benzaldoxins
- substitution
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 238000006467 substitution reaction Methods 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 102000003998 progesterone receptors Human genes 0.000 abstract 1
- 108090000468 progesterone receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 150000007970 thio esters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19809845A DE19809845A1 (de) | 1998-03-03 | 1998-03-03 | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26972A true ID26972A (id) | 2001-02-22 |
Family
ID=7860080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20001706A ID26972A (id) | 1998-03-03 | 1999-02-10 | TIOESTER ASAM S-SUBSTITUSI 11β-BENZALDOKSIN ESTRA-4,9-DIENAKARBONAT, PROSES UNTUK MEMBUAT DAN SEDIAAN FARMASI YANG TERDIRI DARI SENYAWA INI |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6365582B1 (id) |
| EP (1) | EP1060187B1 (id) |
| JP (1) | JP3796405B2 (id) |
| KR (1) | KR100488823B1 (id) |
| CN (1) | CN1208341C (id) |
| AT (1) | ATE237627T1 (id) |
| AU (1) | AU749163B2 (id) |
| BG (1) | BG64735B1 (id) |
| BR (1) | BR9908458A (id) |
| CA (1) | CA2322471C (id) |
| CZ (1) | CZ20003125A3 (id) |
| DE (2) | DE19809845A1 (id) |
| DK (1) | DK1060187T3 (id) |
| EA (1) | EA002766B1 (id) |
| EE (1) | EE04242B1 (id) |
| ES (1) | ES2197634T3 (id) |
| HU (1) | HUP0100962A3 (id) |
| ID (1) | ID26972A (id) |
| IL (1) | IL137851A (id) |
| IS (1) | IS5579A (id) |
| NO (1) | NO316977B1 (id) |
| NZ (1) | NZ506048A (id) |
| PL (1) | PL193687B1 (id) |
| PT (1) | PT1060187E (id) |
| SK (1) | SK284177B6 (id) |
| TR (1) | TR200002506T2 (id) |
| UA (1) | UA59437C2 (id) |
| WO (1) | WO1999045023A1 (id) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| CZ301412B6 (cs) * | 1999-08-31 | 2010-02-24 | Bayer Schering Pharma Aktiengesellschaft | Použití specifických mesoprogestinu jako farmaceutické složky pro výrobu léciva pro hormonální substitucní lécbu |
| US8193252B1 (en) | 1999-08-31 | 2012-06-05 | Bayer Pharma AG | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
| PL353994A1 (en) * | 1999-08-31 | 2003-12-15 | Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| US7629334B1 (en) * | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
| KR100864547B1 (ko) * | 1999-08-31 | 2008-10-20 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질) |
| EP1285927A3 (de) * | 2001-08-16 | 2005-06-29 | Schering Aktiengesellschaft | Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems |
| DE10221034A1 (de) | 2002-05-03 | 2003-11-20 | Schering Ag | 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
| EP1525215B1 (de) * | 2002-08-02 | 2006-09-06 | Schering Aktiengesellschaft | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie |
| DE10236405A1 (de) * | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| DE102005059222B4 (de) * | 2005-12-08 | 2007-10-11 | Bayer Schering Pharma Ag | 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen |
| SI3263112T1 (sl) | 2006-10-24 | 2020-10-30 | Allergan Pharmaceuticals International Limited | Sestavki in metode za zaviranje endometrijskih proliferacij |
| AU2008222829A1 (en) * | 2007-03-07 | 2008-09-12 | Janssen Pharmaceutica N.V. | Steroids derivatives as selective progesterone receptor modulators |
| TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
| DE102009034525A1 (de) * | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| KR102166867B1 (ko) | 2010-03-22 | 2020-10-19 | 앨러간 파마슈티컬스 인터내셔널 리미티드 | 항프로게스틴의 비독성 전달을 위한 조성물들과 그 방법들 |
| EP2664325A1 (en) * | 2012-05-16 | 2013-11-20 | PregLem S.A. | Methods for preventing or treating androgen mediated diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4039677A (en) * | 1976-03-01 | 1977-08-02 | Syntex (U.S.A.) Inc. | Novel 1-phenethylimidazoles |
| ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| DE3504421A1 (de) * | 1985-02-07 | 1986-08-07 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE4332284C2 (de) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US5576310A (en) * | 1994-09-20 | 1996-11-19 | Jenapharm Gmbh | 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds |
| JPH10507461A (ja) | 1994-10-24 | 1998-07-21 | シエーリング アクチエンゲゼルシヤフト | 必要に応じて女性の稔性を調節するための競合的プロゲステロン拮抗物質 |
| ZA9510926B (en) * | 1994-12-23 | 1996-07-03 | Schering Ag | Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| SK124197A3 (en) | 1995-03-14 | 1998-06-03 | Schering Ag | Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility |
-
1998
- 1998-03-03 DE DE19809845A patent/DE19809845A1/de not_active Ceased
-
1999
- 1999-02-10 EE EEP200000500A patent/EE04242B1/xx not_active IP Right Cessation
- 1999-02-10 HU HU0100962A patent/HUP0100962A3/hu unknown
- 1999-02-10 ES ES99915475T patent/ES2197634T3/es not_active Expired - Lifetime
- 1999-02-10 DE DE59905075T patent/DE59905075D1/de not_active Expired - Fee Related
- 1999-02-10 PT PT99915475T patent/PT1060187E/pt unknown
- 1999-02-10 AU AU34067/99A patent/AU749163B2/en not_active Ceased
- 1999-02-10 CA CA002322471A patent/CA2322471C/en not_active Expired - Fee Related
- 1999-02-10 US US09/622,803 patent/US6365582B1/en not_active Expired - Fee Related
- 1999-02-10 KR KR10-2000-7009712A patent/KR100488823B1/ko not_active IP Right Cessation
- 1999-02-10 AT AT99915475T patent/ATE237627T1/de not_active IP Right Cessation
- 1999-02-10 DK DK99915475T patent/DK1060187T3/da active
- 1999-02-10 PL PL99342449A patent/PL193687B1/pl unknown
- 1999-02-10 EP EP99915475A patent/EP1060187B1/de not_active Expired - Lifetime
- 1999-02-10 JP JP2000534565A patent/JP3796405B2/ja not_active Expired - Fee Related
- 1999-02-10 SK SK1305-2000A patent/SK284177B6/sk unknown
- 1999-02-10 CZ CZ20003125A patent/CZ20003125A3/cs unknown
- 1999-02-10 BR BR9908458-9A patent/BR9908458A/pt not_active Application Discontinuation
- 1999-02-10 EA EA200000896A patent/EA002766B1/ru not_active IP Right Cessation
- 1999-02-10 WO PCT/DE1999/000408 patent/WO1999045023A1/de active IP Right Grant
- 1999-02-10 ID IDW20001706A patent/ID26972A/id unknown
- 1999-02-10 TR TR2000/02506T patent/TR200002506T2/xx unknown
- 1999-02-10 NZ NZ506048A patent/NZ506048A/en unknown
- 1999-02-10 CN CNB998036080A patent/CN1208341C/zh not_active Expired - Fee Related
- 1999-02-10 IL IL13785199A patent/IL137851A/xx not_active IP Right Cessation
- 1999-10-02 UA UA2000105635A patent/UA59437C2/uk unknown
-
2000
- 2000-07-28 IS IS5579A patent/IS5579A/is unknown
- 2000-08-28 BG BG104712A patent/BG64735B1/bg unknown
- 2000-09-01 NO NO20004362A patent/NO316977B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID26972A (id) | TIOESTER ASAM S-SUBSTITUSI 11β-BENZALDOKSIN ESTRA-4,9-DIENAKARBONAT, PROSES UNTUK MEMBUAT DAN SEDIAAN FARMASI YANG TERDIRI DARI SENYAWA INI | |
| BRPI0510909A2 (pt) | composto de ligaÇço fÁrmaco-ligante citotàxico, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula e mÉtodo para retardar ou interromper o crescimento de tumor | |
| ATE454379T1 (de) | Benzothiazepin-derivate für die behandlung von hyperlipidemia | |
| CY1107438T1 (el) | Παραγωγα καρβοξυλικου οξεος, τα οποια παρεμποδιζουν την συνδεσιν ιντεγκρινων εις τους υποδοχεις των | |
| DK1073415T3 (da) | Gelerbare farmaceutiske sammensætninger | |
| ID24423A (id) | Sediaan farmasi yang terdiri dari klodronat sebagai bahan aktif dan selulosa mikrokristalin tersilisifikasi sebagai eksipien | |
| IS6852A (is) | Efnasambönd | |
| EA200500088A1 (ru) | Трициклические модуляторы ядерного рецептора стероидного гормона | |
| BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
| DE3819539A1 (de) | Inhibitoren von neutraler endopeptidase | |
| FI962735A (fi) | 2-hydroksi-5-fenylatsobensoehapon johdannaisten käyttö paksusuolen syövän kemialliseen ehkäisyyn ja kemoterapeuttisena aineena | |
| AU4831899A (en) | 5-HT1F agonists | |
| BG106389A (en) | Crystals of the sodium salt of pravastatin | |
| IL146312A (en) | 3-(2-oxo-pyridinyl)-acylamino-propanoic acid derivatives that inhibit the binding of integrins to their receptors and pharmaceutical compositions comprising the same | |
| ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
| TR200504091T2 (tr) | (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim. | |
| BR0308601A (pt) | inibidores de carboxipeptidase b de plasma | |
| DE69714856D1 (de) | Pharmazeutische zusammensetzung enthaltend einen embryonalen extrakt und verfahren zu ihrer herstellung | |
| HUP0301010A2 (hu) | A koleszteril-észter és a viaszészter szintézisét egyaránt gátló vegyületek faggyúmirigy-betegségek kezeléséhez és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0105307A3 (en) | Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors and pharmaceutical compositions thereof and process for preparation the compounds | |
| AU2003208505A1 (en) | Process for preparation of a pharmaceutical composition containing acid labile compounds | |
| Poras et al. | Modulation of disulfide dual ENKephalinase inhibitors (DENKIs) activity by a transient N-protection for pain alleviation by oral route | |
| JPH0769883A (ja) | アロマターゼ阻害剤 | |
| DE59900775D1 (de) | Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate | |
| WO2023288069A1 (en) | Methods of using substituted flavones for treating bone disorders |